Lalit Raj Peddakota from San Francisco, CA, age 44

view source

Position:

Senior Research Associate at Isis Pharmaceuticals

Location:

Greater San Diego Area

Industry:

Biotechnology

Work:

Isis Pharmaceuticals since Sep 2008
Senior Research Associate
Nastech Pharmaceutical Feb 2006 - Aug 2008
Research Associate III

Education:

University of Illinois at Chicago 2002 - 2005
University of Madras

Intranasal Carbetocin Formulations And Methods For The Treatment Of Autism
view source
US Patent:

20120172304, Jul 5, 2012
Filed:

Aug 5, 2011
Appl. No.:

13/204485
Inventors:

Alexis Kays LEONARD - Maple Valley WA, US
Joshua Orion SESTAK - Lawrence KS, US
Henry R. COSTANTINO - Woodinville WA, US
Anthony P. SILENO - Mendham NY, US
Lalit Raj PEDDAKOTA - San Diego CA, US
Kayvon Emile SHARGHI - Chevy Chase MD, US
Garland M. BELLAMY - Santa Fee NM, US
Jason Philip GESTY - Seattle WA, US
Steven C. QUAY - Seattle WA, US
International Classification:

A61K 38/11
A61P 25/28
A61P 25/24
A61P 25/00
A61P 25/22
US Classification:

514 116
Abstract:

Methods and compositions containing oxytocin or an oxytocin analog, such as carbetocin, are provided for the prevention and treatment of autism spectrum disorders, related disorders and symptoms of such disorders. The methods and compositions of this disclosure are effective in the treatment of social withdrawal, eye contact avoidance, repetitive behaviors, anxiety, attention deficit, hyperactivity, depression, loss of speech, verbal communication difficulties, aversion to touch, visual difficulties, comprehension difficulties, and sound and light sensitivity. Additional compositions and methods are provided which employ oxytocin or an oxytocin analog in combination with a secondary or adjunctive therapeutic agent to yield more effective treatment tools against autism spectrum disorders and related disorders.

Intranasal Carbetocin Formulations And Methods For The Treatment Of Autism
view source
US Patent:

20100311655, Dec 9, 2010
Filed:

Sep 28, 2007
Appl. No.:

12/599267
Inventors:

Alexis Kays Leonard - Maple Valley WA, US
Joshua O. Sestak - Lawrence KS, US
Henry R. Costantino - Woodinville WA, US
Anthony P. Sileno - Brookhaven Hamlet NY, US
Lalit Raj Peddakota - San Diego CA, US
Kayvon Emile Sharghi - Seattle WA, US
Garland M. Bellamy - Bothell WA, US
Jason Philip Gesty - Seattle WA, US
Assignee:

MDRNA, INC. - Bothell WA
International Classification:

A61K 38/11
A61P 25/22
A61P 25/24
A61P 25/18
US Classification:

514 116
Abstract:

Methods and compositions containing oxytocin or an oxytocin analog, such as carbetocin, are provided for the prevention and treatment of autism spectrum disorders, related disorders and symptoms of such disorders. The methods and compositions of this disclosure are effective in the treatment of social withdrawal, eye contact avoidance, repetitive behaviors, anxiety, attention deficit, hyperactivity, depression, loss of speech, verbal communication difficulties, aversion to touch, visual difficulties, comprehension difficulties, and sound and light sensitivity. Additional compositions and methods are provided which employ oxytocin or an oxytocin analog in combination with a secondary or adjunctive therapeutic agent to yield more effective treatment tools against autism spectrum disorders and related disorders.

Lalit Raj Peddakota